Shi Yang | Medicine and Dentistry | Best Researcher Award

Prof. Shi Yang | Medicine and Dentistry | Best Researcher Award

Prof. Shi Yang Boston |  University Medical Center | United States

Dr. Shi Yang is a Clinical Professor in the Department of Pathology and Laboratory Medicine at Boston University Chobanian & Avedisian School of Medicine and Director of the Diagnostic Molecular Pathology Laboratory at Boston Medical Center. He earned his MB from Hebei Medical College in China and his MMSc in Pathology from the Chinese Academy of Medical Sciences. With decades of academic and research leadership in molecular diagnostics and cancer pathology, he has become a recognized expert in colorectal and melanoma molecular pathways. His multilingual, patient-centered approach reflects deep dedication to both education and translational science.

Profile

Orcid

Education

Dr. Yang completed his MB at Hebei Medical College and his Master of Medicine in Cancer Pathology at the Cancer Institute of the Chinese Academy of Medical Sciences in Beijing under the mentorship of Professor Quijie Xia. He also pursued advanced training in imaging analysis, molecular techniques, and clinical research at leading institutions in the United States, laying a strong foundation for his expertise in molecular diagnostics and academic pathology.

Experience

Dr. Yang began his career as an Assistant Professor in China before joining Boston University as a faculty member in pathology. He steadily advanced to Clinical Full Professor and Director of the Molecular Pathology Laboratory, where he leads diagnostic innovation and teaching. His career blends clinical service, academic mentorship, and administrative leadership, shaping both institutional practices and the professional growth of countless trainees and colleagues.

Research Interest

Dr. Yang’s research focuses on molecular and epigenetic mechanisms underlying colorectal and melanoma carcinogenesis, particularly serrated polyp pathways, oncogenic mutations, and CpG island methylation. He also investigates molecular diagnostics for hematologic and solid tumors and explores dietary prevention strategies in oncology, such as the effects of green tea in breast cancer. His research bridges basic science with clinical applications, improving diagnostic accuracy and patient outcomes.

Award

Dr. Yang’s professional recognition is reflected in his leadership positions across research centers and university committees. He has been a founding member of key genomic research initiatives and has consistently been appointed to influential roles that drive advancements in molecular pathology, education, and clinical practice. His contributions have strengthened the integration of laboratory science and clinical diagnostics.

Publication Top Notes

Title: Molecular and Clinicopathological Profiling of Clear Cell Renal Cell Carcinoma with Rhabdoid Features: An Integrative Pathway-Based Stratification Approach
Journal: Cancers 
Authors: Zhichun Lu, Qing Zhao, Huihong Xu, Mark H. Katz, David S. Wang, Christopher D. Andry, Shi Yang

Title: A Polymorphism in the Lysyl Oxidase Propeptide Domain Accelerates Carcinogen-induced Cancer
Journal: Boston University Research 
Authors: Shi Yang and collaborators

Title: Tumoral PD-L1 Expression in Desmoplastic Melanoma is Associated with Depth of Invasion, Tumor-Infiltrating CD8 Cytotoxic Lymphocytes and the Mixed Cytomorphological Variant
Journal: Modern Pathology 
Authors: Shi Yang and collaborators

Title: BRAF and Epithelial-Mesenchymal Transition in Primary Cutaneous Melanoma: A Role for Snail and E-cadherin?
Journal: Human Pathology 
Authors: Shi Yang and collaborators

Title: Telomerase (TERT) Promoter Mutations are Infrequent in Merkel Cell Carcinomas
Journal: Journal of the American Academy of Dermatology 
Authors: Shi Yang and collaborators

Conclusion

Dr. Shi Yang is a distinguished pathologist whose expertise in molecular diagnostics and education has made lasting contributions to the field. His commitment to research, patient care, and mentorship demonstrates a unique ability to bridge scientific innovation and clinical application. Through his leadership and scholarly output, he continues to influence pathology practice and academic training globally.

Zsuzsanna Zsengeller | Medicine and Dentistry | Best Innovation Award

Dr. Zsuzsanna Zsengeller | Medicine and Dentistry | Best Innovation Award

Dr Zsuzsanna Zsengeller | BIDMC/ Harvard University | United States

Dr. Zsuzsanna Kinga Zsengeller is an accomplished physician-scientist and Assistant Professor of Medicine at Harvard Medical School. With a robust background in pulmonary biology, respiratory medicine, and molecular pathology, she has contributed significantly to translational research bridging clinical medicine and laboratory science. Her research primarily focuses on mitochondrial dysfunction, redox biology, and mechanisms underlying preeclampsia and kidney diseases. Over the years, Dr. Zsengeller has combined her clinical knowledge and scientific expertise to drive innovative therapies targeting oxidative stress and genetic pathways, gaining recognition as a leader in maternal-fetal health and renal research.

Profile

Orcid

Education

Dr. Zsengeller completed her M.D. in General Medicine at the Albert Szent-Györgyi Medical University, Szeged, Hungary, where she built a strong foundation in clinical medicine and research. She later earned her Ph.D. in Medical Science, specializing in microbiology under the mentorship of Prof. Erno Duda. Her extensive postdoctoral training included research in pulmonary biology at Cincinnati Children’s Hospital and respiratory diseases at Boston Children’s Hospital, where she developed expertise in molecular genetics, oxidative stress mechanisms, and translational therapeutics.

Experience

 Dr. Zsengeller has held diverse academic and professional roles that enriched her clinical and research profile. She served as a staff scientist at Beth Israel Deaconess Medical Center (BIDMC) and a senior scientist at Inotek Pharmaceuticals, contributing to drug discovery programs. Transitioning to academia, she became an instructor at Harvard Medical School before being promoted to Assistant Professor. She has collaborated with biotech companies as a consultant, bridging industry and academic research to foster innovation in therapeutics, particularly for cardiovascular and maternal-fetal health disorders.

Research Interest

Dr. Zsengeller’s research interests revolve around understanding mitochondrial dysfunction, oxidative stress, and genetic pathways in preeclampsia, nephropathy, and cardiovascular diseases. Her laboratory develops targeted antioxidants and redox-modulating therapies aimed at alleviating cellular damage and improving clinical outcomes. She also investigates genetic mechanisms, such as APOL1 variants in kidney disease, to design precision-medicine-based therapies. Her work integrates molecular biology, pharmacology, and clinical applications, positioning her research at the intersection of innovation and patient-centered care.

Awards

Dr. Zsengeller’s innovative research has earned her prestigious recognitions, including the Harvard University Milton Fund Award for pioneering work on mitochondrial-targeted antioxidants in preeclampsia. She has also received major funding from organizations such as the American Heart Association and the Massachusetts Life Science Center for projects on nitric oxide donors and novel redox therapies. Her contributions have positioned her as a sought-after expert and reviewer for national funding bodies, reflecting her impact on advancing research in maternal-fetal and renal health.

Publication Top Notes

Title: Mitigating Oxidative Stress and Anti-Angiogenic State in an In Vitro Model of Preeclampsia by HY-12, an Organofluorine Hydrazone Antioxidant
Journal: Current Issues in Molecular Biology 
Authors: Zsuzsanna K. Zsengellér; Maxim Mastyugin; Adrianna R. Fusco; Bernadett Vlocskó; Maximilian Costa; Coryn Ferguson; Diana Pintye; Réka Eszter Sziva; Saira Salahuddin; Brett C. Young et al.

Title: A Novel Dual-Function Nitric Oxide Donor Therapy for Preeclampsia—A Proof-of-Principle Study in a Murine Model
Journal: Antioxidants 
Authors: Diana Pintye; Réka E. Sziva; Lauren A. Biwer; Esilida Sula Karreci; Sonako Jacas; Maxim Mastyugin; Marianna Török; Brett C. Young; Prakash Jagtap; Garry J. Southan; Zsuzsanna K. Zsengeller

Title: A Novel Dual-Function Redox Modulator Relieves Oxidative Stress and Anti-Angiogenic Response in Placental Villus Explant Exposed to Hypoxia—Relevance for Preeclampsia Therapy
Journal: Biology 
Authors: Diana Pintye; Réka E. Sziva; Maxim Mastyugin; Brett C. Young; Sonako Jacas; Marianna Török; Saira Salahuddin; Prakash Jagtap; Garry J. Southan; Zsuzsanna K. Zsengeller

Title: Smooth Muscle Mineralocorticoid Receptor Promotes Hypertension After Preeclampsia
Journal: Circulation Research 
Authors: Lauren A. Biwer; Qing Lu; Jaime Ibarrola; Alec Stepanian; Joshua J. Man; Brigett V. Carvajal; Nicholas D. Camarda; Zsuzsanna Zsengeller; Geraldine Skurnik; Ellen W. Seely et al.

Title: AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts
Journal: The American Journal of Pathology 
Authors: Ambart E. Covarrubias; Edouard Lecarpentier; Agnes Lo; Saira Salahuddin; Kathryn J. Gray; S. Ananth Karumanchi; Zsuzsanna K. Zsengellér

Conclusion

Dr. Zsengeller exemplifies the qualities of a visionary physician-scientist whose work bridges clinical challenges and molecular innovation. Her dedication to advancing therapies for preeclampsia and renal diseases has significantly influenced translational medicine and inspired collaborations across disciplines. With a strong portfolio of funded projects, publications, and mentorship contributions, she continues to shape the future of maternal-fetal and genetic research. Her commitment to patient-centered innovation and scientific excellence makes her a deserving candidate for prestigious research awards.

Vahabodin Goodarzi | Materials Science | Best Researcher Award

Dr. Vahabodin Goodarzi | Materials Science | Best Researcher Award

Dr. Vahabodin Goodarzi | Baqiyatallah University of Medical Sciences Tehran | Iran

Dr. Vahabodin Goodarzi is a distinguished figure in the field of polymer engineering and materials science, known for his deep-rooted passion for innovation in biomaterials and smart nanocomposites. His extensive body of work spans the development of advanced materials for medical, environmental, and industrial applications. Through his pioneering research in polymeric scaffolds, hydrogels, and electroactive systems, he has carved a niche in tissue engineering and bioresponsive technologies. Dr. Goodarzi has built a global reputation as an expert in designing and modeling multifunctional materials with real-world healthcare impacts. His scientific publications are widely cited, reflecting the relevance and originality of his research. Beyond his technical achievements, he is also recognized for mentoring young researchers, teaching advanced engineering concepts, and bridging the gap between science and innovation. His commitment to sustainable solutions and futuristic materials marks him as a leader and visionary in modern engineering.

Profiles

Scopus
Orcid
Education

Dr. Goodarzi’s academic path has been marked by distinction and a commitment to research excellence. He began his studies in polymer engineering at a leading technical university in Tehran, where his work on nanocomposites laid a strong foundation in material properties and applications. He advanced his knowledge further by pursuing graduate studies at another prominent university, where he focused on polymer blends and their structural performance. His doctoral research explored the creation and behavior of smart nanocomposite systems, integrating sensor and actuator elements for biomedical applications. This work combined theoretical modeling with experimental fabrication, setting the stage for his later innovations in soft robotics and tissue regeneration. Throughout his education, Dr. Goodarzi maintained a top academic standing and contributed to significant advancements in polymer technology. His scholarly journey continues to fuel his multidisciplinary expertise in both fundamental and applied science.

Experience

Dr. Goodarzi’s professional experience reflects a rare blend of academic leadership, experimental rigor, and industry relevance. He has taught a wide range of graduate and undergraduate courses, focusing on elastomers in medicine, biomaterial applications, synthetic skin, and mechanical behavior of polymers. His educational approach encourages hands-on research and fosters critical thinking in the next generation of scientists. In the laboratory, Dr. Goodarzi works extensively with state-of-the-art polymer processing and testing equipment, advancing innovations in biocompatible systems, hydrogels, and nanofiber composites. His research projects are often multidisciplinary, combining insights from chemistry, biology, and engineering. He has contributed to multiple scientific journals, collaborated across international borders, and served as a reviewer and advisor within academic networks. As both a scientist and educator, he leads with integrity and creativity, pushing forward the boundaries of what materials science can achieve.

Research Interests

Dr. Goodarzi’s research is focused on the development of novel materials that interact with biological systems, particularly for applications in regenerative medicine and biomedical engineering. He is passionate about creating smart biomaterials that respond to external stimuli and adapt to complex environments. His work encompasses tissue scaffolding, drug delivery platforms, organ-on-chip technologies, and polymeric systems capable of mimicking natural tissue behavior. He is equally interested in sustainability, designing bioresorbable and biodegradable polymers that contribute to eco-friendly solutions. Dr. Goodarzi applies advanced modeling techniques to understand material behavior under mechanical, thermal, and biological conditions. By integrating simulation with experimental validation, he ensures that his materials perform effectively in real-world applications. His work bridges multiple disciplines, inspiring collaboration across the fields of nanotechnology, bioengineering, and advanced manufacturing.

Awards

Dr. Vahabodin Goodarzi has received multiple prestigious accolades recognizing his excellence in science, research, and academic performance. Early in his academic career, he was awarded top honors at leading Iranian institutions, acknowledging his scholarly potential and innovative thinking. He was later recognized with a young investigator award by a national scientific society, celebrating his contributions to polymer science and engineering. These honors reflect both his technical achievements and his role as a mentor and thought leader in his field. Dr. Goodarzi is a proud member of professional organizations, actively contributing to the global discourse on materials science and sustainability. His awards are not only symbols of personal accomplishment but also affirmations of the impact and value of his research. They highlight his unwavering commitment to pushing boundaries and solving real-world challenges through scientific discovery and innovation.

Publication Top Notes

Strategies for the detection, removal and elimination of antidepressants

Journal: International Journal of Environmental Analytical Chemistry
Authors: Kazım Köse, Demet Yalçın Kehribar, Vahabodin Goodarzi, Lokman Uzun

Polyglycerol sebacate (PGS)-based composite and nanocomposites: properties and applications

Journal: International Journal of Polymeric Materials and Polymeric Biomaterials
Authors: Pardis Yousefi Talouki, Reyhaneh Tamimi, Soheila Zamanlui Benisi, Vahabodin Goodarzi, Shahrokh Shojaei, Saeed Hesami tackalou, Hamid Reza Samadikhah

Cobalt/Bioglass Nanoparticles Enhanced Dermal Regeneration in a 3-Layered Electrospun Scaffold

Journal: Advanced Pharmaceutical Bulletin
Authors: Zahra Hemmati Dezaki, Kazem Parivar, Vahabodin Goodarzi, Mohamad Reza Nourani

Design and manufacture of 3D-cylindrical scaffolds based on PLA/TPU/n-HA with the help of dual salt leaching technique suggested for use in cancellous bone tissue engineering

Journal: Journal of Biomaterials Science, Polymer Edition
Authors: Vahid Faghihi-Rezaei, Hossein Ali Khonkdar, Vahabodin Goodarzi, Goldis Darbemamieh, Maryam Otadi

Preparation and characterization of a new sustainable bio-based elastomer nanocomposites containing poly(glycerol sebacate citrate)/chitosan/n-hydroxyapatite for promising tissue engineering applications

Journal: Journal of Biomaterials Science, Polymer Edition
Authors: Masoomeh Asgharnejad-laskoukalayeh, Hooman Golbaten-Mofrad, Seyed Hassan Jafari, Saba Seyfikar, Pardis Yousefi Talouki, Aliakbar Jafari, Vahabodin Goodarzi, Soheila Zamanlui

Conclusion

Dr. Vahabodin Goodarzi embodies the spirit of a modern scientist—curious, collaborative, and committed to impactful research. Through his dedication to education, innovation, and scientific excellence, he continues to shape the future of materials science. His work addresses real challenges in healthcare and sustainability, offering solutions that improve quality of life and reduce environmental impact. His international collaborations and teaching contributions reflect a deep understanding of both theory and practice. As a role model for aspiring scientists, Dr. Goodarzi represents the best of scientific leadership. He is a strong candidate for recognition at the highest level, not only for his academic achievements but also for his vision, ethics, and ability to inspire progress across disciplines. His lifelong pursuit of innovation and societal benefit makes him an ideal nominee for global awards in science and technology.